A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.
Schwartsmann G, Mans DR, Menke CH, Xavier N, Caleffi M, Ferreira Filho AF, Schunemann H, Kalakun L, Koya R, Pohlman P, Venegas LF.
Schwartsmann G, et al. Among authors: ferreira filho af.
Oncology (Williston Park). 1997 Apr;11(4 Suppl 3):24-9.
Oncology (Williston Park). 1997.
PMID: 9144687
Free article.
Clinical Trial.